Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Bret

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|December 21, 2023
Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myelomaAngélique Bruyer, Laure Dutrieux, Hugues de Boussac, et al.
Cell Reports|December 19, 2025
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid TumorsMalik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Cell Reports|September 12, 2019
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid TumorsMalik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Oncoimmunology|July 20, 2025
CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodiesDjamila Chemlal, Camille Pochard, Valentin Jacquier, et al.
Hematological Oncology|August 23, 2025
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell LymphomaSara Ovejero, Julie Devin, Laura Alibert, et al.
The Journal of Infectious Diseases|November 18, 2020
Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, et al.
The Journal of Infectious Diseases|January 15, 2022
Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, et al.
BMJ Open|June 18, 2024
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy studyCharlotte Planta, Caroline Bret, Delphine Manzoni, et al.
Theranostics|March 14, 2025
Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addictionSara Ovejero, Laura Alibert, Julie Devin, et al.
EMBO Molecular Medicine|June 29, 2026
Single-nuclei UPR profiling by flow cytometry reveals bortezomib resistance mechanisms in multiple myelomaJulien P Gigan, Paulina Garcia-Gonzalez, Angelo Pilotti, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|December 21, 2023
Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myelomaAngélique Bruyer, Laure Dutrieux, Hugues de Boussac, et al.
Cell Reports|December 19, 2025
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid TumorsMalik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Cell Reports|September 12, 2019
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid TumorsMalik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Oncoimmunology|July 20, 2025
CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodiesDjamila Chemlal, Camille Pochard, Valentin Jacquier, et al.
Hematological Oncology|August 23, 2025
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell LymphomaSara Ovejero, Julie Devin, Laura Alibert, et al.
The Journal of Infectious Diseases|November 18, 2020
Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, et al.
The Journal of Infectious Diseases|January 15, 2022
Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, et al.
BMJ Open|June 18, 2024
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy studyCharlotte Planta, Caroline Bret, Delphine Manzoni, et al.
Theranostics|March 14, 2025
Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addictionSara Ovejero, Laura Alibert, Julie Devin, et al.
EMBO Molecular Medicine|June 29, 2026
Single-nuclei UPR profiling by flow cytometry reveals bortezomib resistance mechanisms in multiple myelomaJulien P Gigan, Paulina Garcia-Gonzalez, Angelo Pilotti, et al.
Pageof 5